Lilly COVID-19 Antibody Has Role As Stopgap When Too Late To Vaccinate

Bamlanivimab Prevented Infections In Nursing Home Residents

3D_Coronavirus
Eli Lilly said its antibody, bamlanivimab, is effective at preventing COVID-19 in long-term care facilities. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip